ExPLoRNA Therapeutics raised €758k in a funding round in Dec 2022. The company is based in Warsaw, Poland. Investors in the round: Bill & Melinda Gates Foundation Trust . Data as of 5 Oct 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
